This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

Yesterday, four of Denmark’s largest companies released their financial reports: Demant, Lundbeck, Pandora, and Vestas. All of them are part of the C25 index, which includes the country’s largest ...

A breakthrough in the educational possibilities for non-Danish speakers in Denmark is bound for August, with the start of the ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Investing.com - Eli Lilly's (NYSE: LLY) full-year profit forecast largely surpassed Wall Street expectations on Thursday, as ...

Investing.com - Eli Lilly's full-year profit forecast largely surpassed Wall Street expectations on Thursday, as the ...

Denmark's Novo Nordisk has agreed to pay $70 million to license rights to a drug developed by Ventus Therapeutics with potential in non-alcoholic steatohepatitis (NASH) and several other diseases ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...

Novonesis is a strong business with stable margins and high ROIC, but recent growth rates have declined. See why NVZMF stock ...

Vanguards VEA and VEU exchange trade funds both offer investors exposure to international markets and companies outside of ...